. Author manuscript; available in PMC: 2013 Sep 15.

Published in final edited form as: Cancer Res. 2012 Jul 17;72(18):4846–4855. doi: 10.1158/0008-5472.CAN-12-1879

Table 1.

Median Survival and Percentage Distribution of Neoplasms in CBA Mice^‡

Group	Number of Mice	Median Survival in weeks (CI)^#	Number of Mice
Group	Number of Mice	Median Survival in weeks (CI)^#	Malignant Neoplasm^† (%)	Non-Hematopoietic Neoplasm^* (%)	Hematopoietic Neoplasm^* (%)	Benign Neoplasm (%)
0 Gy Control	92	128.7 (126.3-134.3)	56 (61%)	42 (46%)	28 (30%)	72 (78%)
3 Gy Control	161	94.3 (89.3-99.3)	134 (83%) C:IR p = 0.001	96 (60%) C:IR p = 0.036	65 (40%) C:IR p = 0.14	110 (68%) C:IR p = 0.11
0 Gy Tempol	89	134.1 (132.3-135.6)	35 (39%) T:C p = 0.005	26 (29%) T:C p = 0.031	11 (12%) T:C p = 0.004	60 (67%) T:C p = 0.13
3 Gy Tempol	181	111.7 (108.6-115.1)	102 (56%) T:IR-T p = 0.005	80 (44%) T:IR-T p = 0.012	33 (18%) T:IR-T p = 0.22	121 (67%) T:IR-T p = 0.78

^‡

Statistical comparisons: T:C = 0 Gy T to 0 Gy C; C:IR = 0 Gy C to 3 Gy C; T:IR-T = 0 Gy T to 3 Gy T

CI; 95% confidence interval.

^†

Malignant neoplasms include both HN + non-HN.

Percentages in these two categories do not add up to the total percentage of malignant neoplasms because some mice had both hematopoietic and non-HN.